 | Up a level |
Fennell, Dean A, Ewings, Sean, Ottensmeier, Christian 
ORCID: 0000-0003-3619-1657, Califano, Raffaele, Hanna, Gerard G, Hill, Kayleigh, Danson, Sarah, Steele, Nicola, Nye, Mavis, Johnson, Lucy et al (show 11 more authors)
(2021)
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
LANCET ONCOLOGY, 22 (11).
pp. 1530-1540.
Conibear, John, Chia, Brendan, Ngai, Yenting, Bates, Andrew Tom, Counsell, Nicholas, Patel, Rushil, Eaton, David, Faivre-Finn, Corinne, Fenwick, John, Forster, Martin et al (show 5 more authors)
(2018)
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
BMJ OPEN, 8 (4).
e020690-.